The Advanced Clinical Trial Workshop China-IV (ACT-China IV) will be held in Shenzhen from  November 20 to 23rd in partnership with Chinese Society of Clinical Oncology (CSCO), American Society of Clinical Oncology and the Society of Translational Oncology (STO).

This training will invite more than 10 a domestic and foreign experts to give lectures, 40 experts from tumor drug clinical research institutions, 10 domestic and foreign tumor drug manufacturers in medical department or research and development center in listening to lectures and group discussion. The content of the training involved in tumor drug clinical research and the issues about tumor drug clinical research.

Following is the agenda of the meeting,

ACT China IV_Agenda.pdf